Enanta Pharmaceuticals reported $-33025000 in EBITDA for its first fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Ebitda Change
Abbvie ABBV:US $ 7127M 482M
Acorda Therapeutics ACOR:US $ -4.97M 3.28M
Amgen AMGN:US $ 3341M 185M
Anika Therapeutics ANIK:US $ 0.06M 5.22M
Arrowhead Research ARWR:US $ 44.15M 104.9M
AstraZeneca AZN:LN 4187M 687M
Biocryst Pharmaceuticals BCRX:US $ -49.64M 2.37M
Biogen BIIB:US $ 674.7M 20.2M
Bristol Myers Squibb BMY:US $ 5772M 404M
Clovis Oncology CLVS:US $ -48.44M 2.28M
Enanta Pharmaceuticals ENTA:US $ -33.02M 3.4M
Gilead Sciences GILD:US $ 3422M 1947M
GlaxoSmithKline GSK:LN 3120M 1062M
Halozyme Therapeutics HALO:US $ 76.45M 19.11M
Heron Therapeutics HRTX:US $ -62.2M 9.46M
Insmed INSM:US $ -98173000 1.78M
Intercept Pharmaceuticals ICPT:US $ -9.9M 10.55M
IONIS PHARMACEUT IONS:US $ -53.21M 278.25M
Johnson & Johnson JNJ:US $ 9309M 1549M
Karyopharm Therapeutics KPTI:US $ -34409000 81.51M
Ligand Pharmaceuticals LGND:US $ 4.35M 21.55M
Marinus Pharmaceuticals MRNS:US $ -16.63M 10.4M
Merk MRK:US $ 6179M 492M
Neurocrine Biosciences NBIX:US $ 6.4M 60.6M
Novartis NOVN:VX SF 4552M 346M
Novavax NVAX:US $ 216.06M 1037.12M
Pfizer PFE:US $ 11182M 4046M
Ptc Therapeutics PTCT:US $ -60.21M 5.71M
Sarepta Therapeutics SRPT:US $ -76.16M 19.51M
Vertex Pharmaceuticals VRTX:US $ 1069.3M 159.74M
Vital Therapies VTL:US $ -21.41M 0.26M
YTE INCY:US $ 144.1M 9.29M